Back

Clinical scenario 3: Interpreting the evidence base for rivaroxaban in the treatment of cancer-associated thrombosis: What does it mean for your patient?

29 August 2020 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Treatment challenges in VTE: Exploring solutions with rivaroxaban across three clinical scenarios Venous Thromboembolism Open Access ESC Congress 2020

About the speaker

Photo
Doctor Alok Khorana

6 More presentations in this session

Presentation thumbnail
Welcome and introduction.
Professor S. Konstantinides (Mainz, DE)
Video
Presentation thumbnail
Clinical scenario 1: Anticoagulation for patients with pulmonary embolism from hospital to home: Insights from the 2019 ESC PE guideline updates and HOT-PE trial.
Professor S. Konstantinides (Mainz, DE)
Video
Presentation thumbnail
Q&A.
Video
Presentation thumbnail
Clinical scenario 2: Identifying patients eligible for extended VTE treatment: Insights from EINSTEIN CHOICE and EINSTEIN EXT.
Professor J. Weitz (Hamilton, CA)
Video
Presentation thumbnail
Q&A.
Video

Access the full session

Session thumbnail
Treatment challenges in VTE: Exploring solutions with rivaroxaban across three clinical scenarios
Video

The Event

Event poster

ESC Congress 2020

29 August - 1 September 2020

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources